20% off during October with code SRP2020% OFF DURING OCTOBER
SRP Peptide Pre-Workout frontSRP Peptide Pre-Workout back
COMING SOONPEPTIDE PRE-WORKOUTPRE-ORDER
Free GHK-Cu 100 mg vial with every order through October 11. Click for details. FREE 100 MG VIAL WITH EVERY ORDERSee gift details →
Wolverine Blend BPC-157 and TB-500 research pathways, evidence limitations, and safety chart. HOW WOLVERINE BLEND WORKS Explore Wolverine Blend →
Items in shopping cart:
SRP RESEARCH PULSE

Products are color coded by category

← Return to the Research Vault

Hormone signaling · Compound guide

HGH Fragment 176-191 Research Guide

Explore the mechanisms, study findings and evidence limits behind this research topic.

Product artwork identifies the SRP listing. It does not demonstrate safety or clinical benefit. The evidence guide and its sources follow below.

View product label and documentation →
HGH Fragment 176-191 5mg Research Peptide Vial

Back to the Research Compound Library

Related-fragment preclinical evidence; exact-sequence caution

Evidence reviewed September 13, 2026.

Research overview and identity

HGH Fragment 176-191 names a segment derived from the C-terminal region of human growth hormone. Fragment length and chemical modifications matter: literature on residues 177-191 or on modified AOD-9604 is not automatically direct evidence for an unmodified 176-191 preparation.

Mechanism under investigation

The research rationale is to examine selected metabolic actions of growth-hormone fragments separately from the full hormone. This is a hypothesis about structure and function, not a guarantee that a short fragment retains a desired effect or avoids every effect of the parent hormone.

What the studies report

A 1993 laboratory study investigated the related hGH 177-191 fragment in rat adipose tissue. It reported reduced lipogenesis without a significant increase in the measured lipolysis endpoint. That distinction matters when interpreting simplified claims that all C-terminal fragments directly accelerate fat breakdown. [1]

Limits of the evidence

The cited experiment used a different sequence boundary and a rat-tissue model. It does not establish human weight loss or validate the identity and activity of a retail 176-191 vial. Exact-sequence studies, independently confirmed chemistry and formulation-specific evidence are needed for stronger conclusions.

Matching research material to a paper

Check the material identity, formulation and analytical methods against the study methods. A product name or milligram amount alone does not demonstrate experimental equivalence. Published research does not establish the identity, purity or potency of a retail batch; batch-specific analytical documentation must be assessed separately.

For laboratory research only. Not for human or veterinary use. This guide is educational and contains no dosing, reconstitution or administration instructions.

Sources and further reading

  1. Wu and Ng (1993): metabolic effects of the related hGH 177-191 fragment

Related catalogue listing

HGH Fragment 176-191 product information

Scroll to Top
View Cart